Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Transporter Inhibitors on Probe Drug Cocktail PK
NCT03307252Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Oct 2017
- Primary completion
- May 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of digoxin, furosemide, liquid metformin (Aspargo Labs) and rosuvastatin (5 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Area Under the Concentration-time Curve from 0 to Last Quantifiable Data Point and Maximum Measured Concentration. Started Oct 2017; status: completed.
02
Drugs
digoxinfurosemideliquid metformin (Aspargo Labs)rosuvastatin
Beyond the preview
Go deeper on NCT03307252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03307252.